PLx Pharma Inc.·4

Aug 24, 9:12 AM ET

O'Connor Rita M 4

4 · PLx Pharma Inc. · Filed Aug 24, 2020

Insider Transaction Report

Form 4
Period: 2020-08-20
O'Connor Rita M
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-08-20$3.77/sh+2,300$8,6662,300 total
  • Purchase

    Common Stock

    2020-08-21$3.97/sh+4,050$16,0916,350 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.74 to $3.80, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.85 to $4.10, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.

Documents

1 file
  • 4
    form411577002_08242020.xmlPrimary